Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: Morphometric assessment of the uterus and oviduct

Human Reproduction

Volumn 13, Issue 2, 1998, Pages 269-277

  Slayden, O D ^a   Zelinski Wooten, M B ^a   Chwalisz, K ^b   Stouffer, R L ^a,c   Brenner, R M ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b BAYER PHARMA AG   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antiprogestin; Antiproliferative; Endometrium; Macaque; Oestrogen action

Indexed keywords

ANTIGESTAGEN; CONTRACEPTIVE AGENT; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; ZK 137316;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ENDOMETRIUM CELL; FEMALE; HISTOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEAL PHASE; MITOSIS RATE; MORPHOMETRICS; NONHUMAN; ORGAN WEIGHT; OVIDUCT; PSEUDOPODIUM; RHESUS MONKEY; STROMA; UTERINE TUBE MUCOSA; UTERUS; VEIN DILATATION;

ANIMALIA; MACACA MULATTA;

EID: 0031913611     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.2.269     Document Type: Article

References (39)

1. Baron, S., Vignon, F., Montcourrier, P. et al. (1987) Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res., 47, 1441-1448.
2. Bartelmez, G.W. (1956) Premenstrual and menstrual ischemia and the myth of endometrial arteriovenous anastomoses. Am. J. Anat., 98, 69-95.
3. Bartelmez, G.W. (1957) The form and the functions of the uterine blood vessels in the rhesus monkey. Contrib. Embryol., 36, 153-182.
4. Baulieu, E.-E. (1987) Contragestion by the progesterone antagonist RU 486: a novel approach to human fertility control. Res. Reprod., 19, 3-4.
5. Brenner, R.M. and Slayden, O.D. (1994a) Cyclic changes in the primate oviduct and endometrium. In Knobil, E. and Neill, J.D. (eds), The Physiology of Reproduction. Raven Press, New York, pp. 541-569.
6. Brenner, R.M. and Slayden, O. (1994b) Oestrogen action in the endometrium and oviduct of rhesus monkeys during RU 486 treatment. In Beier, H.M. and Spitz, I.M. (eds). Progesterone Antagonists in Reproductive Medicine and Oncology. Oxford University Press, Cary, NC, pp. 82-97.
7. Brenner, R.M., West, N.B. and McClellan, M.C. (1990) Estrogen and progestin receptors in the reproductive tract of male and female primates. Biol. Reprod., 42, 11-19.
8. Cameron, ST., Critchley, H.O.D., Thong, K.J. et al. (1996) Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum. Reprod. 11, 2518-2562.
9. Carson-Jurica, M.A., Schrader, W.T. and O'Malley, B.W. (1990) Steroid receptor family: structure and functions. Endocr. Rev., 11, 201-220.
10. Chwalisz, K., Hegele-Hartung, C., Fritzemeier, K.-H. et al. (1991) Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors. Endocrinology, 129, 312-322.
11. Chwalisz, K., Hsiu, J.G., Williams, R.F. et al. (1992) Evaluation of the anti-proliferative actions of the progesterone antagonists mifepristone (RU 486) and onapristone (ZK 98.299) on primate endometrium. Soc. Gynecol. Invest. Prog. Abst. 39th Annual Meeting, p. 317.
12. Collins, R.L. and Hodgen, G.D. (1986) Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist? J. Clin. Endocrinol. Metab., 63, 1270-1276.
13. Croxatto, H.B., Fuentealba, B., Salvatierra, A.M. et al. (1997) Clinical strategies for the achievement of endometrial contraception with progesterone antagonists. In Beier, H.M., Harper, M.J.K. and Chwalisz, K. (eds), The Endometrium as a Target for Contraception. Springer-Verlag, Berlin, pp. 259-278.
14. Gemzell-Danielsson, K., Westlund, P., Johannisson, E. et al. (1996) Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 11, 256-264.
15. Giudice, L.C., Dsupin, B.A., Jin, I.H. et al. (1993) Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J. Clin. Endocrinol . Metab., 16, 1115-1122.
16. Hild-Petito, S., Verhage, H.G. and Fazleabas, A.T. (1992) Immunocytochemical localization of estrogen and progestin receptors in the baboon (Papio anubis) uterus during implantation and pregnancy. Endocrinology, 130, 2343-2353.
17. Hodgen, G.D. (1985) Pregnancy prevention by intravaginal delivery of a progesterone antagonist: RU486 tampon for menstrual induction and absorption. Fertil. Steril., 44, 263-267.
18. Ishwad, P.C., Katkam, R.R., Hinduja, I.N. et al. (1993) Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys. Contraception, 48, 57-70.
19. Katkam, R.R., Gopalkrishnan, K., Chwalisz, K. et al. (1995) Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception. Am. J. Obstet. Gynecol., 173, 779-787.
20. Kettel, L.M., Murphy, A.A., Mortola, J.F. et al. (1991) Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil. Steril., 56, 402-407.
21. Koji, T., Chedid, M., Rubin, J.S. et al. (1994) Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J. Cell Biol., 125, 393-401.
22. Liu, J.H., Garzo, G., Morris, S. et al. (1987) Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU 486. J. Clin. Endocrinol. Metab., 65, 1135-1140.
23. Murphy, A.A., Morales, A.J. and Sincich, C.M. (1992) The effect of RU-486 on growth of leiomyomata in monolayer culture. Soc. Gynecol. Invest. Prog. Abst. 39th Annual Meeting, p. 228, no. 239.
24. Murphy, A.A., Kettel, L.M., Morales, A.J. et al. (1995) Endometrial effects of long-term low-dose administration of RU 486. Fertil. Steril., 63, 761-766.
25. Neef, G., Beier, S., Elger, W. et al. (1984) New steroids with antiprogestational and antiglucocorticoid activities. Steroids, 44, 349-372.
26. Neulen, J., Williams, R.F. and Hodgen, G.D. (1990) RU 486 (mifepristone): induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. J. Clin. Endocrinol. Metab., 71, 1074-1075.
27. Neulen, J., Williams, R.F., Breckwoldt, M. et al. (1996) Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Hum. Reprod., 11, 1533-1537.
28. Nieman, L.K., Choate, T.M., Chrousos, G.P. et al. (1987) The progesterone antagonist RU 486. A potential new contraceptive agent. N. Engl. J. Med., 316, 187-191.
29. Okulicz, W.C., Balsamo, M. and Tast, J. (1993) Progesterone regulation of endometrial estrogen receptor and cell proliferation during the late proliferative and secretory phase in artificial menstrual cycles in the rhesus monkey. Biol Reprod., 49, 24-32.
30. Petersen, R.G. (1985) Design and Analysis of Experiments. Marcel Dekker, New York, 268 pp.
31. Reinsch, R.C., Murphy, A.A., Morales, A.J. et al. (1994) The effects of RU 486 and leuprolide acetate on uterine artery blood Mow in the fibroid uterus: a prospective, randomized study. Am. J. Obstet. Gynecol., 170, 1623-1628.
32. Sandow, B.A., West, N.B., Norman, R.L. et al. (1979) Hormonal control of apoptosis in hamster uterine luminal epithelium. Am. J. Anat., 156, 15-36.
33. Slayden, O.D. and Brenner, R.M. (1994) RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaco mulatto). J. Clin. Endocrinol. Metab., 78, 440-448.
34. Slayden, O.D., Hirst, J.J. and Brenner, R.M. (1993) Estrogen action in the reproductive tract during antiprogestin treatment. Endocrinology, 132, 1845-1856.
35. Slayden, O.D., Koji, T. and Brenner, R.M. (1995) Microwave stabilization enhances immunocytochemical detection of estrogen receptor in frozen sections of macaque oviduct. Endocrinology, 136, 4012-4021.
36. Slayden, O.D., Zelinski-Wooten, M.B., Chwalisz, K. et al. (1997) Chronic treatment of cycling rhesus monkeys with low doses of antiprogestin ZK 137 316: dose-dependent endometrial atrophy. J. Soc. Gynecol. Invest., 4, 124A.
37. Wolf, J.P., Hsiu, J.G., Anderson, T.L. et al. (1989) Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil. Steril, 52, 1055-1060.
38. Zelinski-Wooten, M.B., Slayden, O.D., Chwalisz, K. et al. (1997a) Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity. Hum. Reprod., 13, 259-267.
39. Zelinski-Wooten, M.B., Slayden, O.D., Chwalisz, K. et al. (1997b) Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity. J. Soc. Gynecol. Invest. 4, 112A.